# S-TRAC (NCT00375674)

> A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00375674
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Pfizer
- Conditions: Kidney Neoplasms
- Interventions: Sunitinib malate; Placebo
- Enrollment: 674
- Primary outcome: Disease-free Survival (DFS)- Assessed by Blinded Independent Central Review
- Primary outcome: DFS- Assessed by the Investigator [Stratified by University of California Los Angeles Integrated Staging System (UISS) High Risk Group-Intent to Treat Population]

## Commentary we found

- Podcasts: 19
- YouTube: 10
- X threads: 8
- X videos: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=s-trac-nct00375674

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00375674", "email": "<work email>"}; the inbox owner confirms by the emailed link.